Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of ≤500/μL

被引:43
|
作者
Watts, DH
Lambert, JS
Stiehm, ER
Bethel, J
Whitehouse, J
Fowler, MG
Read, J
机构
[1] NICHHD, Pediat Adolescent & Maternal AIDS Branch, Bethesda, MD 20892 USA
[2] Univ Maryland, Inst Human Virol, Rockville, MD USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] NIAID, Div AIDS, Bethesda, MD 20892 USA
关键词
postpartum complications; human immunodeficiency virus-infected women;
D O I
10.1067/mob.2000.105423
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: We sought to describe rates of and risk factors for complications by delivery mode among human immunodeficiency virus-infected women with CD4 counts of less than or equal to 500/mu L. STUDY DESIGN: Complication rates were calculated by delivery mode, as follows: planned cesarean delivery performed without labor or rupture of membranes, other cesarean delivery performed after labor or rupture of membranes, or vaginal delivery. Risk factors were evaluated. RESULTS: Major complications in the planned cesarean delivery (n = 37), other cesarean delivery (n = 95), and vaginal delivery (n = 365) groups were amnionitis or endometritis (16%, 27%, and 7%, respectively), wound infection (5%, 8%, and <1%, respectively), and transfusion (8%, 6%, and 3%, respectively). Any peripartum infection occurred among 16 (18%) of those with a CD4 count of <200/mu L and 43 (13%) with a CD4 count of greater than or equal to 200/mu L (P = .17). On multivariate analyses, factors associated with amnionitis-endometritis were cesarean delivery and African American race, and a factor associated with transfusion was third-trimester anemia. CONCLUSION: Endometritis and wound infection occurred more frequently among human immunodeficiency virus-infected women after cesarean than among women undergoing vaginal delivery; however, complication rates overall were within the range reported in human immunodeficiency virus-negative women, Measures to decrease complications in human immunodeficiency virus-infected women, such as greater use of prophylactic antibiotics, should be assessed.
引用
收藏
页码:100 / 107
页数:8
相关论文
共 50 条
  • [21] THE RELATIONSHIP OF TOTAL LYMPHOCYTE COUNT TO LYMPHOCYTE-CD4 COUNTS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    FOURNIER, AM
    SOSENKO, JM
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 304 (02): : 79 - 82
  • [22] Relationship of pregnancy to human papillornavirus among human immunodeficiency virus-infected women
    Minkoff, Howard
    Xian, Lin Shen
    Watts, D. Heather
    Leighty, Robert
    Hershow, Ron
    Palefsky, Joel
    Tuomala, Ruth
    Neu, Natalie
    Zorrilla, Carmen D.
    Paul, Mary
    Strickler, Howard
    OBSTETRICS AND GYNECOLOGY, 2006, 108 (04): : 953 - 960
  • [23] Primary Prophylaxis for Cryptococcosis With Fluconazole in Human Immunodeficiency Virus-Infected Patients With CD4 T-Cell Counts < 100 Cells/μL and Receiving Antiretroviral Therapy
    Sungkanuparph, Somnuek
    Savetamornkul, Chutchaiwat
    Pattanapongpaiboon, Warisara
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (07) : 967 - 970
  • [24] Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus-Infected Kidney Allograft Recipients
    Suarez, J. F.
    Rosa, R.
    Lorio, M. A.
    Morris, M. I.
    Abbo, L. M.
    Simkins, J.
    Guerra, G.
    Roth, D.
    Kupin, W. L.
    Mattiazzi, A.
    Ciancio, G.
    Chen, L. J.
    Burke, G. W.
    Goldstein, M. J.
    Ruiz, P.
    Camargo, J. F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (08) : 2463 - 2472
  • [25] Changes in total, CD4(+), and CD8(+) lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women
    Tuomala, RE
    Kalish, LA
    Zorilla, C
    Fox, H
    Shearer, W
    Landay, A
    Vermund, SH
    Landesman, S
    Burns, D
    OBSTETRICS AND GYNECOLOGY, 1997, 89 (06): : 967 - 974
  • [26] Phase 1 trial of a single dose of recombinant human interleukin-12, in human immunodeficiency virus-infected patients with 100-500 CD4 cells/μL
    Jacobson, MA
    Hardy, D
    Connick, E
    Watson, J
    DeBruin, M
    JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04): : 1070 - 1076
  • [27] CD4(+) T lymphocyte counts and patterns of mortality among patients infected with human immunodeficiency virus who were enrolled in community programs for clinical research on AIDS
    Saravolatz, L
    Neaton, JD
    Sacks, L
    Deyton, L
    Rhame, F
    Sherer, R
    CLINICAL INFECTIOUS DISEASES, 1996, 22 (03) : 513 - 520
  • [28] A randomised trial of mode of delivery in women infected with the human immunodeficiency virus
    Newell, ML
    Parazzini, F
    Mandelbrot, L
    Peckham, C
    Semprini, A
    Bazin, B
    Darbyshire, J
    Sanchez, E
    Pardi, G
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (03): : 281 - 285
  • [29] The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women
    van Benthem, BHB
    Vernazza, P
    Coutinho, RA
    Prins, M
    AIDS, 2002, 16 (06) : 919 - 924
  • [30] Antiviral CD4 cell response in simian immunodeficiency virus-infected macaques - Reply
    Kent, SJ
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (06): : 1771 - 1772